Alnylam to webcast conference call discussing fourth quarter and full year 2022 financial results

Cambridge, mass.--( business wire )--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that it will report financial results for the fourth quarter and year ending december 31, 2022 on thursday, february 23, 2023, before the u.s. financial markets open.

ALNY Ratings Summary

ALNY Quant Ranking